ALSE
Price:
$0.01
Market Cap:
$398.25K
Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.
Industry
Biotechnology
IPO Date
1994-12-22
Stock Exchange
OTC
Ticker
ALSE
According to Alseres Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.50. This represents a change of -9.83% compared to the average of -0.55 of the last 4 quarters.
The mean historical PE Ratio of Alseres Pharmaceuticals, Inc. over the last ten years is -0.56. The current -0.50 PE Ratio has changed 8.75% with respect to the historical average. Over the past ten years (40 quarters), ALSE's PE Ratio was at its highest in in the December 2013 quarter at 0.75. The PE Ratio was at its lowest in in the September 2006 quarter at -3.65.
Average
-0.56
Median
-1.01
Minimum
-2.90
Maximum
6.25
Discovering the peaks and valleys of Alseres Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.49%
Maximum Annual PE Ratio = 6.25
Minimum Annual Increase = -1541.51%
Minimum Annual PE Ratio = -2.90
| Year | PE Ratio | Change |
|---|---|---|
| 2013 | -0.76 | 156.49% |
| 2012 | -0.30 | -39.61% |
| 2011 | -0.49 | -107.90% |
| 2010 | 6.25 | -1541.51% |
| 2009 | -0.43 | -65.37% |
| 2008 | -1.25 | -56.77% |
| 2007 | -2.90 | 65.54% |
| 2006 | -1.75 | -23.57% |
| 2005 | -2.29 | 32.98% |
| 2004 | -1.72 | -61.92% |
The current PE Ratio of Alseres Pharmaceuticals, Inc. (ALSE) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.52
5-year avg
0.85
10-year avg
-0.56
Alseres Pharmaceuticals, Inc.’s PE Ratio is less than Achiko AG (-0.04), less than Lotus Ventures Inc. (-0.48), greater than Evolva Holding S.A. (-6.64), less than FluroTech Ltd. (-0.05), less than Digicann Ventures Inc. (-0.01), greater than TuHURA Biosciences, Inc. (-1.53), less than Phoenix Life Sciences International Limited (-0.00), greater than Aquarius Surgical Technologies Inc. (-1.18), less than Kiromic BioPharma, Inc. (-0.11), greater than Hemogenyx Pharmaceuticals Plc (-5.70),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.04 | $377.40K | |
| -0.48 | $458.85K | |
| -6.64 | $518.24K | |
| -0.05 | $447.18K | |
| -0.01 | $357.36K | |
| -1.53 | $101.79M | |
| -0.00 | $365.91K | |
| -1.18 | $293.32K | |
| -0.11 | $214.93K | |
| -5.70 | $13.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alseres Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alseres Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alseres Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Alseres Pharmaceuticals, Inc. (ALSE)?
What is the highest PE Ratio for Alseres Pharmaceuticals, Inc. (ALSE)?
What is the 3-year average PE Ratio for Alseres Pharmaceuticals, Inc. (ALSE)?
What is the 5-year average PE Ratio for Alseres Pharmaceuticals, Inc. (ALSE)?
How does the current PE Ratio for Alseres Pharmaceuticals, Inc. (ALSE) compare to its historical average?